title: [Diabetic peripheral neuropathy: reflections and drug-rehabilitative treatment].
abstract: About 60 to 70 percent of people with diabetes have some neuropathy. Diabetic neuropathy can be classified as peripheral, autonomic, proximal, focal and multifocal or mixed. Peripheral neuropathy, the most common type of diabetic neuropathy, causes pain and/or loss of feeling in the toes, feet, legs, hands, and arms; extreme sensitivity to touch, loss of balance and coordination; muscle weakness and loss of reflexes, especially at the ankle, leading to changes in the way a person walks. The aim of this study is to underline the importance of drug and rehabilitative approach in the therapy of peripheral neuropathy, that frequently influences both diabetes mellitus type 1 and diabetes mellitus type 2.
authors.affiliation: Sezione di Medicina Fisica e Riabilitazione, Dipartimento di Neuroscienze, Università, Catania. luciana.pagano@alice.it
authors.forename: Lucia
authors.initials: L
authors.lastname: Pagano
authors.forename: Maria
authors.initials: M
authors.lastname: Proietto
authors.forename: Roberto
authors.initials: R
authors.lastname: Biondi
mesh_terms: D000279:Administration, Cutaneous; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002211:Capsaicin / Q000627:therapeutic use; D003929:Diabetic Neuropathies / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000534:rehabilitation*; D004359:Drug Therapy, Combination; D005081:Exercise Therapy; D006801:Humans; D008405:Massage; D009989:Orthotic Devices; D026741:Physical Therapy Modalities; D015995:Prevalence; D018689:Sensory System Agents / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D012802:Sicily / Q000453:epidemiology; D016896:Treatment Outcome
chemical_list: D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002211:Capsaicin; D018689:Sensory System Agents; D017367:Selective Serotonin Reuptake Inhibitors